A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
about
Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profilingObstructive sleep apnea syndrome and fatty liver: association or causal link?Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameOmega-3 fatty acids for the treatment of non-alcoholic fatty liver disease(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsHigh fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overloadChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceHepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid compositionFunctional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.Epigenetic effects of human breast milk.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Experimental models of non-alcoholic fatty liver disease in rats.High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.Oxidative stress, nitric oxide, and diabetes.Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitisInhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in miceTherapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytesHigh Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats.Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway.Metabolic syndrome, aging and involvement of oxidative stressRegulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs.Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.Eicosapentaenoic acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient miceNutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.Coenzyme Q metabolism is disturbed in high fat diet-induced non-alcoholic fatty liver disease in ratsThe Role of PPARs in Lung Fibrosis.Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathologyLong-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.Enteral High Fat-Polyunsaturated Fatty Acid Blend Alters the Pathogen Composition of the Intestinal Microbiome in Premature Infants with an Enterostomy.Coexistence of hyperlipidemia and acute cerebral ischemia/reperfusion induces severe liver damage in a rat model.Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat.Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liverGarlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model.Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance.Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 micePrescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
P2860
Q21342976-97CD2E05-ED2B-4B32-8692-D2A529C77915Q24612841-ADB789F7-9C65-4714-8B20-1E8324F2AC38Q26775571-16823779-1CDB-43ED-9E8A-3B8B1375AEE8Q26825517-AB9AE950-4E99-4146-A9DF-04D1E41917D9Q27013554-BA3E446C-F26C-4ACE-8CFC-58F58A71FF87Q27316857-88E763F8-17FF-4311-900A-19ADD5D9FABAQ28476015-A5F14CC3-300A-4781-8193-176D1281D803Q33388523-3F682384-5249-4CCF-A0A5-618A0E2A2249Q33531866-C8428E8B-D140-4E11-ABA3-7BC0416BBE87Q33570511-0F5D8F35-83F4-4207-A8FF-21CF4EB44304Q33864337-68F45232-A309-4AC6-9B46-5588D6316DA5Q33886936-105F70EF-9107-46A0-8772-FA75880EC2DCQ33896110-1D8ADED0-D3F4-4CE3-8A3D-16D121F50789Q34072312-4C5906A2-84A6-4871-BCFE-60E4F06EBAF7Q34243636-D6F528A3-069C-4FCD-B991-1EB07B752260Q34397051-FC762D21-FF99-4606-A069-21CD5C194073Q34401755-EEA85F14-D123-4554-8405-2E81A646B452Q34776235-74D0C903-C07E-4864-9B02-C28A0C2AF65EQ34785418-98C09DB0-E98A-4AAE-BF45-7AD267BAC8C0Q34827887-397E2221-D0B5-4F01-921B-5084B992527BQ34989210-6E40F835-1F93-493E-8545-0258924E62EAQ35195226-5852F0D5-5ABE-42B1-A515-7479A6BEE1FEQ35332874-CC967118-6B63-4903-B7F7-CB1867B4CC5CQ35562084-2671B9A7-EF68-46D6-9654-65D2C0BA11BDQ35588868-EB9E1FC4-B9EA-40EA-9B37-0679004C3DAFQ35661889-9E99A98C-A678-4360-8588-A1BE09E13824Q35795775-3DC57A35-3111-4E9B-81D3-2EE84779F955Q35925362-6D319BAD-9E9E-4370-90A8-BEEE38E80045Q35939088-ECA966D8-38D2-4A0F-9A60-4D9404DDADCFQ36038820-BC71DDEC-16AF-4D64-81E4-E2D3921B8953Q36195662-8F6B1465-17B0-4A1B-BD4B-721317A71C1AQ36248214-C3D1EB09-C51A-4223-A52E-57542D024E27Q36384839-E4AB55ED-1163-4129-B45E-97ED45A0BC57Q36482256-985FDB5D-90F1-4633-A5C9-F70D0C946406Q36546630-FB80FB00-2F83-4328-990F-D176E2F07436Q36669223-7C15046E-11FF-4529-A5DE-C4738CBAF034Q36796125-18C14DD6-5E94-47EF-B0F4-0CD2C3F86204Q36803083-EC3927D5-8584-46B8-9269-05879699C488Q37028323-E8E7A6FE-0410-4667-BA00-D0FAB09503DDQ37104877-43661436-73EA-4D5B-8B1A-9E8EDCCA53A3
P2860
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A model of insulin resistance ...... cid treatment on liver injury.
@ast
A model of insulin resistance ...... cid treatment on liver injury.
@en
type
label
A model of insulin resistance ...... cid treatment on liver injury.
@ast
A model of insulin resistance ...... cid treatment on liver injury.
@en
prefLabel
A model of insulin resistance ...... cid treatment on liver injury.
@ast
A model of insulin resistance ...... cid treatment on liver injury.
@en
P2093
P2860
P921
P1476
A model of insulin resistance ...... acid treatment on liver injury
@en
P2093
Alessandro Casini
Antonio Benedetti
Cinzia Candelaresi
Deborah Pacetti
Gianna Ferretti
Liliana Nobili
Marco Marzioni
Renata Salzano
Samuele De Minicis
Soeren Sigmund
P2860
P304
P356
10.2353/AJPATH.2006.050953
P407
P577
2006-09-01T00:00:00Z